「pr」の検索結果
238件：171～175件目を表示
-
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens...
http://www.senju.co.jp/english/rd/ -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye...
https://www.senju.co.jp/english/rd/pipeline.html -
お知らせ | 千寿製薬株式会社
April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approv...
http://www.senju.co.jp/english/news/ -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
す。 #1:井上 佐智子, 川島 素子, 坪田 一男：ドライアイとは？原因から最新の治療まで、ファルマシア, 2014 50(3): 201-6 #2: Papas EB. The global prevalence of dry eye disease: A Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254-66. #3: Uni...
https://www.senju.co.jp/rd/policy/ -
Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical
ra through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fields.Senju Pharmaceutical Co., Ltd. will start the medical device business ane...
https://www.senju.co.jp/english/about/business/device.html